Status:
COMPLETED
Effect of Esmolol on Pain Due to Rocuronium
Lead Sponsor:
Ankara Diskapi Training and Research Hospital
Conditions:
Injection Site Irritation
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
90 American society of anesthesiology (ASA) physical status I and II patients undergoing general anesthesia for elective surgery will be included in the study. Patients will be randomized into three g...
Detailed Description
Patients will be observed after injection of rocuronium 0.05mg/kg, then immediately asked if they have pain in the arm. The response are assessed; discomfort, pain, and withdrawal of the hand are reco...
Eligibility Criteria
Inclusion
- ASA physical status I and II patients
- Undergoing general anesthesia for elective surgery
Exclusion
- Known allergy to esmolol or lidocaine
- Chronic pain
- Pregnancy
- Withdrawal of consent by the patient
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01824758
Start Date
March 1 2013
End Date
May 1 2013
Last Update
October 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diskapi Teaching and Research Hospital
Ankara, Altindag, Turkey (Türkiye)